Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

ConferenceMedicine and clinical research · Milan, Italy

ESMO Breast Cancer 2027

ESMO Breast Cancer 2027, the European Society for Medical Oncology’s annual breast cancer congress, takes place at Allianz MiCo, Milan, from 12 to 14 May 2027 with a virtual platform. This guide covers areas consistent with the congress scope, readiness checks for abstracts, and what to consider before the 2 February 2027 abstract deadline.

Pubrica InsightsEditorial team, reviewed by a subject specialist
Next deadline
2 February 2027
Last checked
10 November 2026
Organiser
European Society for Medical Oncology
Sources
1
Submit an abstract

Key dates

Abstract deadline
2 February 2027
Full paper deadline
Abstracts only, or not stated
Conference dates
12 May 2027 – 14 May 2027
Details last checked
10 November 2026
Submit an abstract

About the conference

Conference
ESMO Breast Cancer 2027
Organiser
European Society for Medical Oncology
Venue
Milan, Italy
Scope
ESMO's annual breast cancer congress at Allianz MiCo, Milan, with a virtual platform; abstract submission is open until 2 February 2027.
Submission types
Abstracts; confirm formats and word limits on the official page

Topics consistent with the programme

  • Clinical trials of systemic therapies in early and advanced breast cancer
  • Biomarkers and molecular subtyping to guide breast cancer treatment
  • Surgical and radiotherapy approaches in breast cancer
  • Survivorship, quality of life and supportive care
  • Breast cancer in specific populations, such as young or older patients
  • Translational research on resistance to endocrine and targeted therapies

Based on the published scope; the official page sets out the full themes and requirements.

Is your work a fit? Check before you submit

  1. The work addresses breast cancer research, treatment or care.
  2. The abstract presents original results with clear methods and conclusions.
  3. Clinical data are reported with ethical approval and appropriate reporting standards.
  4. The abstract category and submission rules have been confirmed on the official ESMO meeting page.
  5. The abstract is complete, approved by all co-authors and submitted before 2 February 2027.

Why This Conference Matters

Breast cancer care continues to evolve with new targeted therapies, biomarkers and de-escalation strategies. ESMO Breast Cancer brings together medical oncologists, surgeons, radiation oncologists, pathologists and researchers with a shared focus on the disease. Presenting at the congress allows authors to share findings with a specialist multidisciplinary audience, both in Milan and online, and to discuss their implications for practice and research.

Who Should Submit

Academic backgrounds

  • Medical oncology
  • Breast surgery
  • Radiation oncology
  • Pathology and molecular diagnostics
  • Oncology nursing and supportive care

Institutions and sectors

  • Cancer centres and university hospitals
  • Oncology research institutes
  • Pharmaceutical and biotechnology companies
  • Patient advocacy and survivorship organisations

What Reviewers Typically Value

  1. Original clinical or translational data relevant to breast cancer treatment decisions.
  2. Robust designs and transparent reporting of outcomes.
  3. Biomarker studies with clear clinical implications.
  4. Work addressing unmet needs in specific patient groups.

Ideas You Could Develop

Real-world outcomes with a targeted therapyA cohort study of outcomes and toxicity with a newer targeted agent in routine practice.
Circulating tumour DNA and recurrenceA translational study evaluating circulating tumour DNA for detecting early recurrence after curative treatment.
Quality of life in young survivorsA study examining long-term quality of life and fertility concerns among young breast cancer survivors.

Your Plan to the Deadline

A suggested schedule working back from 2 February 2027. Adjust it to the stage your work has reached.

  1. By 22 Dec 2026

    Open the official call for abstracts; confirm the tracks, word limit, format and author rules.

  2. By 5 Jan 2027

    Agree the key result, the authors and the presenting author.

  3. By 19 Jan 2027

    Draft the structured abstract to the word limit, with results stated as numbers.

  4. By 26 Jan 2027

    Circulate to co-authors and an independent reader; revise.

  5. By 31 Jan 2027

    Final checks: title, author affiliations, conflicts of interest and track selection.

  6. By 2 Feb 2027

    Submit through the official abstract system before the deadline.

What you gain

  • Feedback from peers working on the same questions.
  • A citable abstract or proceedings paper.
  • Contacts for collaboration, employment and future funding.
  • A step towards a full journal article.

What happens after you submit

  1. Acknowledgement: the abstract system confirms receipt; keep the submission number.
  2. Review: the scientific committee scores abstracts against the track criteria.
  3. Decision: accepted abstracts are assigned to an oral, poster or e-poster session.
  4. Registration: presenting authors usually must register by a stated date.
  5. Publication: accepted abstracts or papers may appear in the conference proceedings or journal supplement.

What the Organisers Are Looking For

ESMO invites abstracts across breast cancer research and care, from translational science to surgery, radiotherapy, systemic therapy and survivorship. Organisers are likely to look for original, well-reported clinical and translational work relevant to practice. Abstract submission is open until 2 February 2027. Authors should confirm categories, formatting and embargo rules on the official ESMO meeting page.

Read the official pageThis guide summarises the opportunity. Confirm deadlines, eligibility and requirements on the official page before you plan your work, and record the date you checked it.Open the official page

Expert help

How Pubrica Can Help

Pubrica’s subject specialists can help you prepare the abstract, full paper, poster or slides, planned back from the deadline. You remain the author of your work.

Abstract writingA structured abstract written to the conference’s word limit and format. Full paper writingFull conference papers written to the proceedings template. Poster preparationScientific posters designed to the conference’s size and layout rules. Presentation slidesOral presentation slides prepared for the allotted time. Editing and proofreadingSubject-specialist editing of abstracts and papers before submission. BiostatisticsStatistical analysis and review of results.
Go to the official page

FAQs

Questions Researchers Ask

The next published deadline is 2 February 2027. Dates can change, so confirm them on the official page before you plan your work.

Some oncology congresses accept trial-in-progress abstracts in a dedicated category, but this varies. Authors should check the official ESMO meeting page to confirm whether such submissions are accepted for this congress.

The official page lists abstract submission; check it for any full paper or proceedings option.

Yes. Pubrica’s specialists can review, write, edit and format your abstract, paper, poster or slides. You remain the author and the person responsible for the submission.

Sources

  1. European Society for Medical Oncology. (2026). ESMO Breast Cancer 2027. Retrieved 10 November 2026, from https://www.esmo.org/meeting-calendar/esmo-breast-cancer-2027

How to cite this page

Pubrica Insights. (2026). ESMO Breast Cancer 2027. Pubrica. https://pubrica.com/insights/calls-and-conferences/esmo-breast-cancer-2027/

  • Breast cancer
  • ESMO Breast 2027
  • Oncology
  • Milan
  • Abstracts

Other Open Conferences

Closes 16 November 202636th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2027)Australia Closes 18 November 2026ESCMID Global 2027Sweden Closes 19 November 2026ESC Preventive Cardiology 2027Portugal

All calls, conferences and fundingAbstract writing

ESMO Breast 2027Next deadline 2 February 2027

Official page
Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.